$7.71
al cierre: Nov 6 EDT
$7.71
0.000.00%
Pre-comercialización: 7:48 PM EDT
Comments
Loading...
Orientación y previsiones
Xeris Biopharma Holdings emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/06/2025 | XERS | Xeris Biopharma Holdings | FY | 2025 | — | — | — | $285.00M | $290.00M | $286.75M | |
08/07/2025 | XERS | Xeris Biopharma Holdings | FY | 2025 | — | — | — | $280.00M | $290.00M | $270.01M | |
06/03/2025 | XERS | Xeris Biopharma Holdings | FY | 2030 | — | — | — | $750.00M | $750.00M | — | |
06/03/2025 | XERS | Xeris Biopharma Holdings | FY | 2025 | — | — | — | $260.00M | $275.00M | $269.16M | |
05/08/2025 | XERS | Xeris Biopharma Holdings | FY | 2025 | — | — | — | $260.00M | $275.00M | $262.30M | |
03/06/2025 | XERS | Xeris Biopharma Holdings | FY | 2025 | — | — | — | $255.00M | $275.00M | $239.77M | |
01/10/2025 | XERS | Xeris Biopharma Holdings | FY | 2024 | — | — | — | $203.00M | $203.00M | $199.70M | |
01/10/2025 | XERS | Xeris Biopharma Holdings | Q4 | 2024 | — | — | — | $60.00M | $60.00M | $56.74M | |
11/08/2024 | XERS | Xeris Biopharma Holdings | FY | 2024 | — | — | — | $198.00M | $202.00M | $193.40M | |
08/08/2024 | XERS | Xeris Biopharma Holdings | FY | 2024 | — | — | — | $190.00M | $200.00M | $187.35M | |
07/08/2024 | XERS | Xeris Biopharma Holdings | Q2 | 2024 | — | — | — | $47.00M | — | $44.89M | |
05/09/2024 | XERS | Xeris Biopharma Holdings | FY | 2024 | — | — | — | $175.00M | $200.00M | $184.43M | |
03/06/2024 | XERS | Xeris Biopharma Holdings | FY | 2024 | — | — | — | $170.00M | $200.00M | $188.01M | |
01/04/2024 | XERS | Xeris Biopharma Holdings | FY | 2023 | — | — | — | $165.00M | $165.00M | $161.96M | |
11/09/2023 | XERS | Xeris Biopharma Holdings | FY | 2023 | — | — | — | $160.00M | $165.00M | $158.23M | |
10/16/2023 | XERS | Xeris Biopharma Holdings | FY | 2023 | — | — | — | $155.00M | $165.00M | $158.23M | |
08/08/2023 | XERS | Xeris Biopharma Holdings | FY | 2023 | — | — | — | $145.00M | $165.00M | $149.35M | |
05/09/2023 | XERS | Xeris Biopharma Holdings | FY | 2023 | — | — | — | $135.00M | $165.00M | $146.90M | |
03/08/2023 | XERS | Xeris Biopharma Holdings | FY | 2023 | — | — | — | $135.00M | $165.00M | $152.31M |
PREGUNTAS FRECUENTES
¿Cuál es la orientación más reciente de Xeris Biopharma Holdings (XERS)?
En los últimos meses no se han comunicado orientaciones específicas de ventas o beneficios para Xeris Biopharma Holdings.
Explora orientación y previsión sobre todos los valores.